Immune Activation and CD8+ T-Cell Differentiation towards Senescence in HIV-1 Infection
Open accessThe DOI matches its Crossref record; 72 of the 72 references it cites were found in a registry or an index.
Abstract
Progress in the fight against the HIV/AIDS epidemic is hindered by our failure to elucidate the precise reasons for the onset of immunodeficiency in HIV-1 infection. Increasing evidence suggests that elevated immune activation is associated with poor outcome in HIV-1 pathogenesis. However, the basis of this association remains unclear. Through ex vivo analysis of virus-specific CD8(+) T-cells and the use of an in vitro model of naïve CD8(+) T-cell priming, we show that the activation level and the differentiation state of T-cells are closely related. Acute HIV-1 infection induces massive activation of CD8(+) T-cells, affecting many cell populations, not only those specific for HIV-1, which results in further differentiation of these cells. HIV disease progression correlates with increased proportions of highly differentiated CD8(+) T-cells, which exhibit characteristics of replicative senescence and probably indicate a decline in T-cell competence of the infected person. The differentiation of CD8(+) and CD4(+) T-cells towards a state of replicative senescence is a natural process. It can be driven by excessive levels of immune stimulation. This may be part of the mechanism through which HIV-1-mediated immune activation exhausts the capacity of the immune system.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Terminally differentiated (CD28−CD57+) T lymphocytes are characterized by strong effector functions such as expression of cytotoxins (e.g., Perforin and Granzyme B) and cytolytic capacity, and a marked inflammatory profile by way of increase proinflammatory cytokine (e.g., IFN-γ, TNF-α, MIP-1β) secretion [86].”
From Aging of the immune system: Focus on inflammation and vaccination (2016) · cites this paper as [86]
Experimental — accuracy not yet measuredIn the citing paper
“The increased proportion of terminally differentiated oligoclonal effector memory T-cell populations in the elderly has been shown to be the consequence of recurrent or chronic immune activation [86].”
From Aging of the immune system: Focus on inflammation and vaccination (2016) · cites this paper as [86]
In the citing paper
“However, terminally differentiated T cells are constrained by limited proliferative capabilities in tandem with short telomeres, and to a large extent, have been defined as approaching senescence [86, 87].”
From Aging of the immune system: Focus on inflammation and vaccination (2016) · cites this paper as [86]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Phenotypic Analysis of Antigen-Specific T Lymphocytes
Altman, J. D., Moss, P. A. H., Goulder, P. J. R., Barouch, D. H., McHeyzer-Williams, M. G., Bell, J. I., McMichael, A. J., & Davis, M. M. (1996) · Science · doi:10.1126/science.274.5284.94 · Cited by 3,544 · cited 1×
“HLA–peptide tetrameric complexes (‘‘tetramers’’) were produced as previously described (Altman et al. 1996) and included the following specificity: A2 HIV p17-SLYNTVATL and pol-ILKEPVHGV, A2 CMV pp65-NLVPMVATV, A2 EBV BMLF1-GLCTLVAML, A2 influenza matrix-GILGFVFTL, A2 melanA-ELAGIGILTV, B7 HIV nef-TPGPGVRYPL and gp41-…”
MethodSelf-citationKoup, R. A., Safrit, J. T., Cao, Y., Andrews, C. A., McLeod, G., Borkowsky, W., Farthing, C., & Ho, D. D. (1994) · Journal of Virology · doi:10.1128/jvi.68.7.4650-4655.1994 · Cited by 2,495 · cited 1×
“During primary human immunodeficiency virus 1 (HIV-1) infection, the immune system appears to respond appropriately in order to prevent viral spread, with the mounting of a strong HIV-specific CD8þ T-cell response and a corresponding reduction in viraemia (Koup et al. 1994).”
BackgroundCounting Antigen-Specific CD8 T Cells: A Reevaluation of Bystander Activation during Viral Infection
Murali-Krishna, K., Altman, J. D., Suresh, M., Sourdive, D. J. D., Zajac, A. J., Miller, J. D., Slansky, J., & Ahmed, R. (1998) · Immunity · doi:10.1016/s1074-7613(00)80470-7 · Cited by 1,943 · cited 1×
“T-cell compartment. Our data indicate that HIV-1 infection results in immune activation not only directly, but also indirectly, with the activation of cells specific for non-HIV antigens. In recent years, the role of potential bystander activation has been reevaluated and is now considered less important (”
BackgroundChanges in thymic function with age and during the treatment of HIV infection
Douek, D. C., McFarland, R. D., Keiser, P. H., Gage, E. A., Massey, J. M., Haynes, B. F., Polis, M. A., Haase, A. T., Feinberg, M. B., Sullivan#, J. L., et al. (1998) · Nature · doi:10.1038/25374 · Cited by 1,893 · cited 1×
“2002c), HIV-infected individuals are characterised by decreased thymic output (Douek et al. 1998) and reduced naı̈ve T-cell numbers (Roederer et al.”
BackgroundLineage relationship and protective immunity of memory CD8 T cell subsets
Wherry, E. J., Teichgräber, V., Becker, T. C., Masopust, D., Kaech, S. M., Antia, R., von Andrian, U. H., & Ahmed, R. (2003) · Nature Immunology · doi:10.1038/ni889 · Cited by 1,864 · cited 1×
“’’ Protective immunity has recently been associated with the proliferative capacity of virus-specific CD8 T-cells in the mouse model (Wherry et al. 2003).”
BackgroundMemory CD8+ T cells vary in differentiation phenotype in different persistent virus infections
Appay, V., Dunbar, P. R., Callan, M., Klenerman, P., Gillespie, G. M. A., Papagno, L., Ogg, G. S., King, A., Lechner, F., Spina, C. A., et al. (2002) · Nature Medicine · doi:10.1038/nm0402-379 · Cited by 1,571 · cited 13×
“One could speculate that the association between different stages of CD8þ T-cell differentiation and viral specificity of these cells, as previously described (Appay et al. 2002a; Tussey et al. 2003), may be related to the stimulation intensity received by the cells from priming onwards.”
BackgroundMethodInfluentialSelf-citationPhenotypic and functional separation of memory and effector human CD8+ T cells
Hamann, D., Baars, P. A., Rep, M. H. G., Hooibrink, B., Kerkhof-Garde, S. R., Klein, M. R., & Lier, R. A. W. V. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.9.1407 · Cited by 1,366 · cited 1×
“The assumption that CD28 /CD27 T-cells are protective effector cells is mainly based on the fact that these cells possess strong cytotoxic potential, expressing high levels of perforin, as seen ex vivo (Hamann et al. 1997).”
BackgroundBorrow, P., Lewicki, H., Wei, X., Horwitz, M. S., Peffer, N., Meyers, H., Nelson, J. A., Gairin, J. E., Hahn, B. H., Oldstone, M. B. A., et al. (1997) · Nature Medicine · doi:10.1038/nm0297-205 · Cited by 1,183 · cited 1×
“Continuous adaptive mutation (Borrow et al. 1997) and destruction or impairment of elements necessary for an optimal immune response (e.”
BackgroundBrenchley, J. M., Karandikar, N. J., Betts, M. R., Ambrozak, D. R., Hill, B. J., Crotty, L. E., Casazza, J. P., Kuruppu, J., Migueles, S. A., Connors, M., et al. (2003) · Blood · doi:10.1182/blood-2002-07-2103 · Cited by 1,073 · cited 4×
“…following priming of T-cells in vitro (see Figure 2C), although this remained relatively modest (below 10%), possibly due to the high susceptibility to activation induced cells death of CD57þ Tcells (Brenchley et al. 2003; unpublished data) in the interleukin-2 (IL-2)-supplemented assay conditions.”
BackgroundInfluentialMigueles, S. A., Laborico, A. C., Shupert, W. L., Sabbaghian, M. S., Rabin, R., Hallahan, C. W., Baarle, D. V., Kostense, S., Miedema, F., McLaughlin, M., et al. (2002) · Nature Immunology · doi:10.1038/ni845 · Cited by 1,005 · cited 1×
“This is supported by Migueles et al. (2002), who showed that HIV-1-infected long-term nonprogressors are characterised by HIV-1-specific CD8þ T-cells that maintain a strong proliferative capacity following in vitro stimulation (cells defined mainly as CD45ROþ/CD28þ/CD27þ early-differentiated cells).”
Background
Research works printed but not linked: 3
- Gerna, 1998, New Microbiol, 21, 293
- Giorgi, 1993, J Acquir Immune Defic Syndr, 6, 904
- Hellerstein, 2003, J Clin Invest, 112, 956, 10.1172/JCI200317533 · doi:10.1172/jci200317533 · Paper page
Cited by
Items 301–400 of 476
Autaa, G., Korenkov, D. A., van Beek, J., Pellegrin, I., Parfait, B., van Baarle, D., Launay, O., Tartour, É., & Appay, V. (2025) · Immunity & Ageing · doi:10.1186/s12979-025-00542-8 · Cited by 13
“CD57 ⁺ T cells have typically undergone numerous rounds of replication, and as a result, exhibit reduced proliferative capacity, telomere shortening [30, 38], and increased senescence-associated β-galactosidase (SA-β-gal) activity [37].”
Self-citationTinarwo, P., Zewotir, T. T., Yende‐Zuma, N., Garrett, N., & North, D. (2019) · Infectious Diseases and Therapy · doi:10.1007/s40121-019-0235-4 · Cited by 11
“the lymphocytes were the strongest, as expected, because the CD4 cells are a T cell type [83]”
BackgroundWinchester, N., Panigrahi, S., Haria, A., Chakraborty, A., Su, X., Chen, B., Morris, S. R., Clagett, B. M., Juchnowski, S. M., Yadavalli, R., et al. (2023) · The Journal of Immunology · doi:10.4049/jimmunol.2300267 · Cited by 10
Iancu, E. M., Baumgaertner, P., Wieckowski, S., Speiser, D. E., & Rufer, N. (2010) · BioMed Research International · doi:10.1155/2011/452606 · Cited by 10
“Briefly a 1 : 1 mixture of specific and control target cells labeled with CMTMR is added to fluorescently sorted antigenspecific CD8+ T-cells and incubated for 4 h in the presence of degranulation marker CD107a- and CD8-specific mAbs.”
Self-citationDying T cells trigger autoimmunity in HIV
Rowland-Jones, S. L., & Dong, T. (2007) · Nature Medicine · doi:10.1038/nm1207-1413 · Cited by 10
Self-citationWürsch-Molina, D., Ormsby, C. E., Romero‐Rodríguez, D. P., Olvera-García, G., Zúñiga, J., Jiang, W., Pérez-Patrigeón, S., & Espinosa, E. (2016) · Disease Markers · doi:10.1155/2016/9510756 · Cited by 10
“However, the expression of Ki67 does not always correlate with that of CD38, and thesemolecules show different predictive value depending on the T cell subset on which they are analyzed [5, 10–12].”
BackgroundMullins, T. L. K., Li, S. X., Bethel, J., Goodenow, M. M., Hudey, S. N., & Sleasman, J. W. (2018) · Journal of Clinical Virology · doi:10.1016/j.jcv.2018.02.001 · Cited by 11
Ikarashi, D., Kitano, S., Ishida, K., Nakatsura, T., Shimodate, H., Tsuyukubo, T., Tamura, D., Kato, R., Sugai, T., & Obara, W. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.564714 · Cited by 10
“HIV infection, cancer, and autoimmune diseases, the Ki67 expression pattern in T cells has been reported to evaluate antigen-specific T cell expansion (12, 13).”
BackgroundMkhwanazi, N. P., Thobakgale, C., van der Stok, M., Reddy, S., Mncube, Z., Chonco, F., Walker, B. D., Altfeld, M. A., Goulder, P., & Ndung’u, T. (2010) · Virology · doi:10.1016/j.virol.2010.06.002 · Cited by 9
“HIV-specific CD8+ T cells may also display different differentiation status and activation profiles (Appay and Sauce, 2008; Papagno et al., 2004).”
Persistent subclinical immune defects in HIV-1-infected children treated with antiretroviral therapy
van den Heuvel, D., Driessen, G. J. A., Berkowska, M. A., van der Burg, M., Langerak, A. W., Zhao, D., Charif, H., Hartwig, N. G., van Rossum, A. M. C., Fraaij, P. L. A., et al. (2015) · AIDS · doi:10.1097/qad.0000000000000765 · Cited by 14
“These HIV-specific cells display reduced cytolytic potential and are more prone to apoptosis [9–11], mechanisms that could contribute to impaired clearing of HIV [12,13].”
BackgroundCrawford, T. Q., Hecht, F. M., Pilcher, C. D., Ndhlovu, L. C., & Barbour, J. D. (2013) · PLoS ONE · doi:10.1371/journal.pone.0077412 · Cited by 10
T cell immune responses to HIV-1
Vasan, S. (2006) · Frontiers in bioscience · doi:10.2741/2235 · Cited by 9
de Andrade, R. M., Andrade, A. F. B., Lazaro, M. A., Vieira, M. M. M., Barros, P. O., Borner, A. R. S., Silva-Filho, R. G., Santos, J. O., Brindeiro, R., Tanuri, A., et al. (2010) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e3181d6003b · Cited by 10
“Some works have shown that macrophages and HIV-specific and nonspecific activated CD8 T lymphocytes from infected patients are important sources of IL-1b, IL-12, and TNF-a, with impact on clinical disease progression.(11,21) As infection proceeds, a preferential loss of the T-helper 1 (Th1)-like responses gradually re…”
BackgroundParfieniuk‐Kowerda, A., Jaroszewicz, J., & Flisiak, R. (2015) · Clinical and Experimental Hepatology · doi:10.5114/ceh.2015.51805 · Cited by 9
“These cells are more prone to undergo apoptosis due to a higher expression of Fas and FasL, but also are able to secrete large quantities of IFN-γ upon TCR (T cell receptor) stimulation [13-15].”
BackgroundLupini, C., Quaglia, G., Mescolini, G., Russo, E., Salaroli, R., Forni, M., Boldini, S., & Catelli, E. (2020) · Poultry Science · doi:10.1016/j.psj.2020.05.054 · Cited by 9
“A reduction in the proportion of CD41/CD81 and an increase of CD81, associated with immunological disfunctions, have been also reported in humans during prolonged infections with human immunodeficiency virus and cytomegalovirus (Ouyang et al., 2004; Papagno et al., 2004).”
BackgroundSo Pathogenic or So What?—A Brief Overview of SIV Pathogenesis with an Emphasis on Cure Research
Kleinman, A. J., Pandrea, I., & Apetrei, C. (2022) · Viruses · doi:10.3390/v14010135 · Cited by 11
Kwakye-Nuako, G., Boampong, J. N., Dong, M. K., Obiri‐Yeboah, D., Opoku, Y. K., Amoako-Sakyi, D., & Asare, K. K. (2016) · Asian Pacific Journal of Tropical Disease · doi:10.1016/s2222-1808(16)61127-1 · Cited by 9
“The CD4 cell depletion is attributed to HIV virus priming the CD8 T lymphocytes to kill the CD4 T lymphocytes cells[16-18].”
BackgroundHoji, A., Popescu, I., Pipeling, M. R., Shah, P. D., Winters, S. A., & McDyer, J. F. (2019) · The Journal of Immunology · doi:10.4049/jimmunol.1900399 · Cited by 10
“cell lectin-like receptor subfamily G member 1 (KLRG1) (20) and CD57 (21, 22).”
BackgroundSubclinical herpesvirus shedding among HIV-1-infected men on antiretroviral therapy
Agudelo-Hernandez, A., Chen, Y., Bullotta, A., Buchanan, W. G., Klamar-Blain, C., Borowski, L., Riddler, S. A., Rinaldo, C. R., & Macatangay, B. J. C. (2017) · AIDS · doi:10.1097/qad.0000000000001602 · Cited by 9
Changing roles of CD3+CD8low T cells in combating HIV-1 infection
Zhang, X., Wang, X., Qin, L., Lu, X., Liu, Z., Li, Z., Yuan, L., Wang, R., Jin, J., Ma, Z., et al. (2022) · Chinese Medical Journal · doi:10.1097/cm9.0000000000002458 · Cited by 8
“Indeed, high levels of CD8 T-cell immune activation have been associated with poor outcomes for HIV-1 individuals, as confirmed in several studies.([33,34]) In the present study, the classical activation of CD3CD8 T cells, particularly CD3CD8 T cells, was the greatest in the first month of infection and then gradually…”
ResultZhang, Y., Ji, J., Xie, K., Cai, M., Wang, R., Zhang, X., Chen, X., Zhang, Y., Wu, H., Wang, W., et al. (2024) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2024.1344778 · Cited by 9
Li, Y., Hong, J., & Zhang, L. (2022) · Infectious Diseases & Immunity · doi:10.1097/id9.0000000000000045 · Cited by 10
“Continuous exposure of T cells to high concentrations of HIV antigen leads to a state of severe T cell exhaustion that prevents their normal killing ability.([23]) T cell exhaustion is accompanied by an increase in the type and expression of immune checkpoint (IC)molecules, including PD- 1, TIM-3, CTLA-4, TIGIT, and L…”
BackgroundKasahara, T. M., Hygino, J., de Andrade, R. M., Monteiro, C., Sacramento, P. M., Andrade, A. F. B., & Bento, C. A. M. (2015) · Human Immunology · doi:10.1016/j.humimm.2015.09.023 · Cited by 9
Cheng, S., Lien, C.-E., Hsieh, S., Cheng, C., Liu, W.-D., Lo, C.-L., Ko, W., Chen, Y., Huang, C., Chang, H., et al. (2022) · Vaccines · doi:10.3390/vaccines11010018 · Cited by 7
Hoffman, R. M., Jamieson, B. D., Bosch, R. J., Currier, J. S., Ramirez, C. M., Schmid, I., Zhu, Y., Bennett, K. K., & Mitsuyasu, R. T. (2011) · Journal of Clinical Immunology · doi:10.1007/s10875-011-9550-6 · Cited by 7
“This is consistent with previous data showing that progression of HIV infection is associated with a depletion of naïve CD4+ Tcells and a corresponding increase in intermediate and late-differentiated CD8+ T lymphocytes [21, 26].”
Ghosn, J., Abdoul, H., Fellahi, S., Merlet, A., Salmon, D., Morini, J., Deleuze, J., Blacher, J., Capeau, J., Bastard, J., et al. (2020) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2020.0182 · Cited by 7
Franco-Leyva, T., Torres, O. H., Saez, M. E., Boera-Carnicero, G., Santos, Á., Clotet, S., Albert-Jares, D., El-Ebiary, Y., Agustí-Martí, M., Casademont, J., et al. (2022) · Journal of Leukocyte Biology · doi:10.1002/jlb.5ma0422-370r · Cited by 7
Reacciones y alteraciones del sistema inmune durante la infección por el VIH-1
Guarín, C. J. M., Fernández, M. E. M., & López, M. T. R. (2006) · Institutional Repository University of Antioquia (University of Antioquia) · Cited by 7
d’Ettorre, G., Ceccarelli, G., Serafino, S., Giustini, N., Cavallari, E. N., Bianchi, L., Pavone, P., Bellelli, V., Turriziani, O., Antonelli, G., et al. (2016) · Journal of Medical Virology · doi:10.1002/jmv.24475 · Cited by 7
“Previous findings have suggested measuring CD4þCD38þ/DRþ T cells and CD8þCD38þ/DRþ T cells together with the CD4þ T cell count and HIV-RNA levels to more accurately predict the risk of progression to AIDS [Carbone et al., 2000; Papagno et al., 2004].”
ResultBertoli, D., Re, A., Chiarini, M., Sottini, A., Serana, F., Giustini, V., Roccaro, A. M., Cattaneo, C. M., Caimi, L., Rossi, G., et al. (2016) · Scientific Reports · doi:10.1038/srep37995 · Cited by 7
IL-18 Responsiveness Defines Limitations in Immune Help for Specialized FcRγ– NK Cells
Anderko, R. R., Rinaldo, C. R., & Mailliard, R. B. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.2000430 · Cited by 8
Emerging roles of senolytics/senomorphics in HIV-related co-morbidities
Kaur, G., Rahman, M. S., Shaikh, S. B., Panda, K., Chinnapaiyan, S., Estevez, M. S., Xia, L., Unwalla, H. J., & Rahman, I. (2024) · Biochemical Pharmacology · doi:10.1016/j.bcp.2024.116179 · Cited by 7
Therapeutic immunization in HIV infection
Autran, B., Loes, S. K., & Katlama, C. (2006) · Current Opinion in HIV and AIDS · doi:10.1097/01.coh.0000232348.15909.c6 · Cited by 6
Kovacs, A. A. Z., Kono, N., Wang, C., Wang, D., Frederick, T., Operskalski, E. A., Tien, P. C., French, A. L., Minkoff, H., Kassaye, S., et al. (2019) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiz589 · Cited by 6
HIV-1-Specific CD11c+ CD8+ T Cells Display Low PD-1 Expression and Strong Anti-HIV-1 Activity
Guo, A.-L., Zhao, J., Gao, L., Huang, H.-H., Zhang, J., Zhang, C., Song, J., Xu, R., Fan, X., Shi, M., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.757457 · Cited by 7
“particularly HIV-1-specific CD8 T cells, and PD-1 expression on HIV-1-specific T cells is the leading marker of exhaustion associated with HIV-1-specific T cell dysfunction and disease progression (12, 22, 23), we first monitored the expression of”
BackgroundZhang, Z., Hu, S.-W., Liu, J., Xu, J., He, L., Jiang, Y., Wang, Y., & Shang, H. (2011) · Japanese Journal of Infectious Diseases · doi:10.7883/yoken.64.423 · Cited by 6
“Although activation of T cells leads to the restoration of memory CD4+ T cells and immunocompetence, it can also generate more targets for HIV that permit ongoing HIV replication and can cause clonal exhaustion, which probably indicates a decline in T cell competence (7).”
BackgroundBurastero, S. E., Figini, M., Frigerio, B., Lusso, P., Mollica, L., & Lopalco, L. (2009) · Journal of Translational Medicine · doi:10.1186/1479-5876-7-101 · Cited by 6
Immune Phenotype and Postoperative Complications After Elective Surgery
Moris, D., Barfield, R., Chan, C. C. W., Chasse, S., Stempora, L., Xie, J., Plichta, J. K., Thacker, J. K. M., Harpole, D. H., Purves, J. T., et al. (2023) · Annals of Surgery · doi:10.1097/sla.0000000000005864 · Cited by 8
T cell memory revisited using single telomere length analysis
Roger, L., Miners, K. L., Leonard, L., Grimstead, J. W., Price, D. A., Baird, D. M., & Ladell, K. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1100535 · Cited by 5
TB and HIV induced immunosenescence: where do vaccines play a role?
Singh, M., Patel, B., Seo, M., Ahn, P., Wais, N., Shen, H., Nakka, S., Kishore, P., & Venketaraman, V. (2024) · Frontiers in Aging · doi:10.3389/fragi.2024.1385963 · Cited by 8
Treating HIV-1 infection: what might the future hold?
Lichterfeld, M. D., & Zachary, K. C. (2011) · Therapeutic Advances in Chronic Disease · doi:10.1177/2040622311411601 · Cited by 10
T-cell receptor transfer for boosting HIV-1-specific T-cell immunity in HIV-1-infected patients
Mummert, C., Hofmann, C., Hückelhoven, A. G., Bergmann, S., Mueller-Schmucker, S. M., Harrer, E. G., Dörrie, J., Schaft, N., & Harrer, T. (2016) · AIDS · doi:10.1097/qad.0000000000001176 · Cited by 5
“HIV-1-infected patients have high frequencies of terminal-differentiated effector T cells [40] and there is a persistent T-cell activation even in treated patients with suppressed viremia [41].”
BackgroundMiki, S., Kawai, Y., Nakayama‐Hosoya, K., Iwabuchi, R., Terahara, K., Tsunetsugu‐Yokota, Y., Koga, M., Matano, T., Kaneko, S., & Kawana‐Tachikawa, A. (2022) · Journal of Virology · doi:10.1128/jvi.02217-21 · Cited by 10
The Effects of Aging on HIV Disease
Kalayjian, R. C., & Al‐Harthi, L. (2009) · Humana Press eBooks · doi:10.1007/978-1-59745-434-6_16 · Cited by 5
Shrivastava, S., Kottilil, S., Sherman, K. E., Masur, H., & Tang, L. (2021) · Viruses · doi:10.3390/v13102074 · Cited by 4
IMPACT OF HIV INFECTION AND TUBERCULOSIS ON THE PERIPHERAL BLOOD T-CELL DIFFERENTIATION
Vasil’eva, E. V., Kudryavtsev, I. V., Маximov, G. V., Verbov, V. N., Серебрякова, М. К., Петрович, Т. А., & Тотолян, А. А. (2017) · Russian Journal of Infection and Immunity · doi:10.15789/2220-7619-2017-2-151-161 · Cited by 4
Nicoli, F., Gallerani, E., Sicurella, M., Pacifico, S., Cafaro, A., Ensoli, B., Marconi, P., Caputo, A., & Gavioli, R. (2020) · Vaccines · doi:10.3390/vaccines8020274 · Cited by 4
Tinarwo, P., Zewotir, T. T., & North, D. (2020) · AIDS Research and Treatment · doi:10.1155/2020/1379676 · Cited by 6
“Among the strongest CD4 count covariates are the lymphocytes that are B or T cells [25, 75, 76], which also consists of the CD4 cells, a Tcell type [77].”
BackgroundPremature Onset of Cardiovascular Disease in HIV-Infected Individuals: The Drugs and the Virus
Maisa, A., Westhorpe, C. L. V., Elliott, J., Jaworowski, A., Hearps, A. C., Dart, A. M., Hoy, J., & Crowe, S. M. (2010) · HIV Therapy · doi:10.2217/hiv.10.53 · Cited by 4
Downey, J. S., Attaf, M., Moyle, G. J., Gazzard, B., Gotch, F. M., & Imami, N. (2011) · AIDS · doi:10.1097/qad.0b013e32834b35a9 · Cited by 4
“In addition, reduced numbers of CD27þ T cells were seen in infected individuals: an observation previously associated with reduced CD4þ T-cell help to CD8þ T cells [6,19].”
BackgroundSaxena, V., Bichare, S., Singh, D., Ghate, M., Godbole, S., Kulkarni, S., Gangakhedkar, R., Paranjape, R., & Thakar, M. R. (2016) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2016.0210 · Cited by 4
Aksak‐Wąs, B., Skonieczna‐Żydecka, K., Parczewski, M., Hrynkiewicz, R., Lewandowski, F., Serwin, K., Mielczak, K., Lenkiewicz, F., & Niedźwiedzka‐Rystwej, P. (2025) · HIV Medicine · doi:10.1111/hiv.70020 · Cited by 4
Nuvor, S. V., Whittle, H. C., Rowland‐Jones, S., & Jaye, A. (2012) · World Journal of AIDS · doi:10.4236/wja.2012.22014 · Cited by 3
“Early HIV-1 infection is associated with intense immune activation [20], which results in increased T lymphocyte proliferation at the acute stage of infection [21].”
BackgroundSelf-citationLipid metabolic reprogramming of hepatic CD4 + T cells during SIV infection
Clain, J. A., Boutrais, S., Dewatines, J., Racine, G., Rabezanahary, H., Droit, A., Zghidi‐Abouzid, O., & Estaquier, J. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.01687-23 · Cited by 5
“The inefficiency of the immune response in clearing microbes leading to chronic immune activation is associated with the exhaustion and the loss of effector T cells (19, 20).”
BackgroundFlores, F., Lovato, M., Wilsmann, C. G., Gazoni, F. L., Silveira, F., Caron, L. F., & Beirão, B. C. B. (2012) · Pesquisa Veterinária Brasileira · doi:10.1590/s0100-736x2012000600005 · Cited by 3
HIV and COVID-19 Coinfection: A Synergism That Results in More Severe Forms of Reactive Arthritis
Santacruz, J. C., Mantilla, M. J., Pulido, S., Arzuaga, Á., Bello, J., & Londoño, J. D. (2021) · Cureus · doi:10.7759/cureus.19396 · Cited by 3
“The loss of CD4+ T cells in both entities is demonstrated by the increase in biomarkers such as CD38, HLA-DR, and programmed death 1 (PD-1) that are expressed in activated T cells, contributing to their depletion [15].”
BackgroundHIV-Associated Chronic Immune Activation: Current Understandings and Therapeutic Intervention
Vanderford, T. H., Adamski, J., & Silvestri, G. (2010) · HIV Therapy · doi:10.2217/hiv.10.2 · Cited by 3
HIV Infection as a Model of Accelerated Immunosenescence
Appay, V., Sauce, D., & Kelleher, A. D. (2019) · Springer eBooks · doi:10.1007/978-3-319-99375-1_50 · Cited by 5
Self-citationVγ2Vδ2 T Cells are Skewed Toward a Terminal Differentiation Phenotype in Untreated HIV Infection
Hartjen, P., Meyer‐Olson, D., Lehmann, C., Stellbrink, H., van Lunzen, J., & Wiesch, J. S. Z. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit141 · Cited by 3
Safety and Immunogenicity of SARS-CoV-2 S-2P Protein Vaccine MVC-COV1901 in People Living with HIVPreprint
Cheng, S., Lien, C.-E., Hsieh, S., Cheng, C., Liu, W.-D., Lo, C.-L., Ko, W., Chen, Y., Huang, C., Chang, H., et al. (2021) · medRxiv · doi:10.1101/2021.12.08.21267439 · Cited by 3
Ageing with HIV-1: immunological challenges for effective vaccination
Saint-Charles, P., Didierlaurent, A. M., & Appay, V. (2025) · Immunity & Ageing · doi:10.1186/s12979-025-00544-6 · Cited by 3
Self-citationCD57-Expressing Lymphocytes: From Chronic Viral Response to Age-Related Inflammation
Vallejo-Bermúdez, I. M., Miranda-Echagüe, M. R., Fernández-Álvarez, S., Reina-Alfonso, I., Blanca-Pariente, L., Batista-Duharte, A., & Pera, A. (2026) · Cells · doi:10.3390/cells15050403 · Cited by 4
Akagi, J., Baba, H., Sekine, T., & Ogawa, K. (2018) · Oncology Letters · doi:10.3892/ol.2018.8512 · Cited by 3
Zvarych, L., Panchenko, V. V., Golyarnik, N., Belayev, O. A., & Bаzyка, D. (2023) · Проблеми радіаційної медицини та радіобіології = Problems of Radiation Medicine and Radiobiology · doi:10.33145/2304-8336-2023-28-286-315 · Cited by 2
Caetano, D. G., Toledo, T. S., de Lima, A. C. S., Giacoia-Gripp, C. B. W., de Almeida, D. V., de Lima, S. M. B., Azevedo, A. D. S., Morata, M., Grinsztejn, B. G. J., Cardoso, S. W., et al. (2024) · Vaccines · doi:10.3390/vaccines12060578 · Cited by 2
Klimova, E. M., Lavinska, O. V., & Drozdova, L. A. (2025) · Immunology Letters · doi:10.1016/j.imlet.2025.107033 · Cited by 4
Akagi, J., & Baba, H. (2018) · Oncology Letters · doi:10.3892/ol.2018.8451 · Cited by 2
“The primary organs affected by cancer in these patients were the stomach (9), colon (23),”
InfluentialImmunopathogenesis of HIV-1 Infection
Aldrovandi, G. M., & Cerini, C. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-2702-9.00112-4 · Cited by 2
Diversity of CD28null T Cells in the Elderly: A Glimpse in a Biological Adaptation of Aging
Griffin, P. C., Michel, J. J., & Vallejo, A. N. (2017) · Springer eBooks · doi:10.1007/978-3-319-64597-1_87-1 · Cited by 2
Dabee, S., Mkhize, N. N., Jaspan, H. B., Lewis, D. A., Gumbi, P. P., & Passmore, J.-A. S. (2020) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2019.0268 · Cited by 2
HIV Infection as a Model of Accelerated Immunosenescence
Appay, V., & Sauce, D. (2009) · Springer eBooks · doi:10.1007/978-1-4020-9063-9_50 · Cited by 3
“These subpopulations tend to lose the capacity to produce IL-2 and present a decline of their proliferative capacity, associated with a shortening of telomere lengths, so that highly differentiated cells (CD28/CD57+) have been considered as approaching end-stage senescent cells [67, 96].”
BackgroundSelf-citationPhysiologic Changes In A Non-Human Primate Model Of HIV-Associated Pulmonary Arterial Hypertension
George, M. P., Champion, H. C., Brower, A., Guyach, S., Janssen, C. F., Tarantelli, R., Murphy, J., Carney, J., Strollo, D. C., Morris, A., et al. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm-conference.2012.185.1_meetingabstracts.a3431 · Cited by 2
Zech, M., Veliça, P., & Stauss, H. J. (2015) · Current Gene Therapy · doi:10.2174/1566523215666150126123037 · Cited by 1
“Furthermore, effector T cells were shown not to be able to differentiate into memory cells in vitro [36] and have shorter telomeres and less telomerase activity than memory T cells [37].”
BackgroundKaur, G., Wang, Q., Tjitropranoto, A., Unwalla, H. J., & Rahman, I. (2024) · Experimental Lung Research · doi:10.1080/01902148.2024.2414974 · Cited by 1
Exhaustion of CD4+ T cells is associated with bacterial load in active tuberculosis patients
Guo, C., Yan, H., Li, H., Shang, Y., Zhang, X., Yao, C., Wang, W., Pang, Y., & Gao, M. (2025) · Microbial Pathogenesis · doi:10.1016/j.micpath.2025.108103 · Cited by 1
Castro, R. C., Gravina, H. D., Sugiyama, F. H. C., Lamarre, Y., Fontanari, C., Powell, B. H., Gololobova, O. A., Liao, Z., Almeida, F. B. D. R., Kashima, S. H., et al. (2025) · Aging Cell · doi:10.1111/acel.70320 · Cited by 1
“CD8 + and CD4 + T cells has been associated with terminally differentiated cells and immunosenescence in PLWH (Papagno et al. 2004; Elias Junior et al. 2024; Brenchley et al. 2003; Méndez-Lagares et al. 2013; Deeks et al. 2012).”
Qian, Z., Long, H., Wu, H., Xie, J., Chen, S., Wu, J., & Cai, S. (2026) · Journal of Immunology Research · doi:10.1155/jimr/8683624 · Cited by 3
Roche, S., Garch, H. E., Brunet, S., Poulet, H., Iwaz, J., Écochard, R., & Vanhems, P. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056135 · Cited by 2
“This expansion is a hallmark of HIV and FIV infections [29,30,31].”
Izadi, N., Goetz, M. B., & Graber, C. J. (2011) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e31823d3277 · Cited by 1
Understanding Immune Senescence, Exhaustion, and Immune Activation in HIV–Tuberculosis Coinfection
Shankar, E. M., Saeidi, A., Vignesh, R., Velu, V., & Larsson, M. (2017) · Springer eBooks · doi:10.1007/978-3-319-64597-1_131-1 · Cited by 1
Understanding Immune Senescence, Exhaustion, and Immune Activation in HIV–Tuberculosis Coinfection
Shankar, E. M., Saeidi, A., Vignesh, R., Velu, V., & Larsson, M. (2019) · Springer eBooks · doi:10.1007/978-3-319-99375-1_131 · Cited by 1
Hartigan-O’Connor, D. J., & Brander, C. (2023) · Oxford University Press eBooks · doi:10.1093/med/9780197679098.003.0006 · Cited by 1
Klimova, E. M., Drozdova, L. A., Lavinska, O. V., Boyko, V. V., Buchneva, O. V., & Pogulaylo, O. I. (2024) · EMERGENCY MEDICINE · doi:10.22141/2224-0586.20.5.2024.1733 · Cited by 2
Sankapal, S. R. (2015) · D-Scholarship@Pitt (University of Pittsburgh) · Cited by 1
Divergence in CD8+ T cell epitopes of HIV -1 as an immune escape mechanism
Colleton, B. A. (2007) · D-Scholarship@Pitt (University of Pittsburgh) · Cited by 1
Immune Mechanisms of Viral Control in HIV-2 Infection
Moysi, E., de Silva, T. I., & Rowland-Jones, S. L. (2011) · Elsevier eBooks · doi:10.1016/b978-0-12-387715-4.00011-3 · Cited by 1
Self-citationImmunopathogenesis of HIV-1 Infection
Aldrovandi, G. M., Cerini, C., & Tobin, N. H. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-40181-4.00110-9 · Cited by 1
Covariate random effects on the CD4 count variation during HIV disease progression in women
Tinarwo, P., Zewotir, T. T., & North, D. (2019) · HIV/AIDS - Research and Palliative Care · doi:10.2147/hiv.s193652 · Cited by 1
Diversity of CD28null T Cells in the Elderly: A Glimpse in a Biological Adaptation of Aging
Griffin, P. C., Michel, J. J., & Vallejo, A. N. (2019) · Springer eBooks · doi:10.1007/978-3-319-99375-1_87 · Cited by 1
Immunologic Memory: T Cells in Humans
Iglesias, M. C., Appay, V., & Moris, A. (2012) · Wiley eBooks · doi:10.1002/9781118345313.ch5 · Cited by 1
Self-citationImmunity and protection, the unfolding of a tale
Zanetti, M. (2007) · Immunologic Research · doi:10.1007/s12026-007-0005-3 · Cited by 2
“Not surprisingly, chronic HIV infection and excessive antigen stimulation drives cells into a state of replicative senescence with prevalence of CD57 CD8 T cells [61, 63].”
BackgroundInnate and adaptive cellular immunity in chronic HCV and HIV-1 infection
Gonzalez, V. D. (2009) · Figshare · Cited by 1
Huang, K. H., Loutfy, M. R., Boulet, S., Toma, E., Tsoukas, C. M., & Bernard, N. F. (2008) · Antiviral Therapy · doi:10.1177/135965350901400304 · Cited by 1
“In HIV infection, reactivation as well as bystander activation by CMV leads to significantly higher immune activation in HIV–CMV-coinfected individuals [36,38].”
BackgroundThe role of microbial translocation and gut microbiota in HIV-1 infection
Vesterbacka, J. (2017) · Figshare · Cited by 1
The role of parasites in the invasion ecology of Harmonia axyridis
Berry, K. M. (2017) · Stirling Online Research Repository (University of Stirling) · Cited by 1
Moreno, Y. M. F. (2007) · doi:10.47749/t/unicamp.2007.411989 · Cited by 5
HIV-Associated Immune Exhaustion
Appay, V., Lissina, A., & Sauce, D. (2014) · Springer eBooks · doi:10.1007/978-1-4614-9610-6_186-1 · Cited by 1
“Moreover, these memory T cells are characterized by a lack of CD28 and an increased expression of CD57, a cell-surface marker associated with cellular senescence (Papagno et al. 2004).”
BackgroundSelf-citationROLE OF GBV-C AND HUMAN HERPES VIRUS COINFECTIONS IN AIDS DEVELOPMENT IN HIV-1 SEROCONVERTERS
Shen, C. (2014) · D-Scholarship@Pitt (University of Pittsburgh)
Ferrari, V. (2005) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2005.tde-05042007-131529
Human natural killer cell activation and differentiation in health and viral infection
Björkström, N. K. (2011) · Figshare
Metadata
- Authors
- Papagno, L., Spina, C. A., Marchant, A., Salio, M., Rufer, N., Little, S., Dong, T., Chesney, G., Waters, A., Easterbrook, P., Dunbar, P. R., Shepherd, D., Cerundolo, V., Emery, V., Griffiths, P., Conlon, C., McMichael, A. J., Richman, D. D., Rowland-Jones, S. L., & Appay, V.
- Affiliations
- University of Milan (IT)
- University of California San Diego (US)
- John Radcliffe Hospital (GB)
- The Royal Free Hospital (GB)
- ORCID
- Venue
- PLoS Biology
- Publisher
- Public Library of Science (PLoS)
- Published
- 2004-02-17
- Volume
- 2
- Issue
- 2
- Pages
- e20
- ISSN
- 1544-9173 (ISSN-L)
- 1545-7885
- PMC
- PMC340937
- OpenAlex
- W1965845165
- Cited by
- 478
- References
- 71
- Citations by year
- 2026: 10 · 2025: 10 · 2024: 14 · 2023: 10 · 2022: 20 · 2021: 18 · 2020: 13 · 2019: 20 · 2018: 22 · 2017: 21 · 2016: 29 · 2015: 23 · 2014: 22 · 2013: 28 · 2012: 31
- FWCI
- 3.53
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS Biology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- IRIS (submittedVersion)
- Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) (submittedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- UCL Discovery (University College London) (submittedVersion)
- Research Portal (King's College London) (submittedVersion)
- SERVAL (Université de Lausanne) (submittedVersion, other-oa)
- Funders
- Wellcome Trust
- Cancer Research UK
- King's College London
- European Commission (QLK2-CT)
- National Institutes of Health
- Center for AIDS Research, University of Washington
- University of California, San Diego
- Medical Research Council
- National Institute of Allergy and Infectious Diseases (AI-29164, R24AI106039, R37AI029164)
- Topics
- Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Health Sciences › Medicine › Infectious Diseases › HIV-related health complications and treatments
- Keywords
- HIV-1 infection, immune activation, CD8+ T cell differentiation, replicative senescence, T cell exhaustion, acute HIV-1 infection, disease progression, CD4+ T cells, virus-specific T cells, T cell priming, immunodeficiency
- MeSH terms
- Aging, Cell Differentiation, Humans, Lymphocyte Activation, CD4-Positive T-Lymphocytes, HIV Infections, CD8-Positive T-Lymphocytes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.